Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6a86831170132d420b8f108ce9eafef |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15d8c66687dab53268f5dad3374a7eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c3cb653ab73fbd0bb26b70ea870827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdce8d050773e21e1665ad8a9983a87c |
publicationDate |
2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-108778283-A |
titleOfInvention |
Therapeutic substance abuses obstacle composition and method |
abstract |
The present invention relates to compositions and method that obstacle and habituation are abused for therapeutic substance.In particular it relates to the combination of the benzodiazepine such as Oxazepam of the cortisol synthesis inhibitor of low dosage such as Metopirone and low dosage.The compositions and methods of the invention include the pharmaceutical composition and method of safe and effective treatment animals and humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115317478-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115317478-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069515-A |
priorityDate |
2016-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |